Press "Enter" to skip to content

Pfizer-BioNTech vaccine could be ready for approval by mid-October — but there are still ‘unknowns’

Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday.

cnn topstories?d=yIl2AUoC8zA cnn topstories?d=7Q72WNTAKBA cnn topstories?i=U0iLbsm3n8E:WcLFYTbDEnI:V sGLiPBpWU cnn topstories?d=qj6IDK7rITs cnn topstories?i=U0iLbsm3n8E:WcLFYTbDEnI:gIN9vFwOqvQ

U0iLbsm3n8E
Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *